MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol

MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol

Abstract Background Peripheral artery disease (PAD) affects over 230 million people worldwide and is due to systemic atherosclerosis with etiology linked to chronic inflammation, hypertension, and smoking status. PAD is associated with walking impairment and mobility loss as well as a high prevalenc...

Full description

Bibliographic Details
Main Authors: Katherine M. Reitz, Andrew D. Althouse, Daniel E. Forman, Brian S. Zuckerbraun, Yoram Vodovotz, Ruben Zamora, Robert L. Raffai, Daniel E. Hall, Edith Tzeng
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Peripheral artery disease
Intermittent claudication
Metformin
Anti-inflammatory agents
Clinical trial protocol
Atherosclerosis
Online Access:https://doi.org/10.1186/s12872-023-03047-8

Internet

https://doi.org/10.1186/s12872-023-03047-8

Similar Items